-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Maintains Buy on ClearPoint Neuro, Raises Price Target to $30

Benzinga·06/18/2026 17:55:00
Listen to the news
B. Riley Securities analyst Anderson Schock maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and raises the price target from $20 to $30.